Skip to content

A Comparative Pharmaceutical and Clinical study of Mruddarshrung ointment prepared by two different base media and evaluating its efficacy on palm and sole infection

A Comparative Pharmaceutical-Analytical and Clinical study of Mruddarshrung malahar prepared by two types of siktha taila thereby evaluating its efficacy in Vipadika with special reference to Palmo Plantar Psoriasis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063803
Enrollment
60
Registered
2024-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Government PG Ayurvedic College and Hospital Varanasi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals of Vipadika having pani pada sphutan and teevra vedna as clinical symptoms. 2. Patients have a history within six months of the onset of symptoms. 3. Uncomplicated cases with a classical picture of Vipadika.

Exclusion criteria

Exclusion criteria: 1. Patient not willing for trial. 2. Patients having sphutan and teevra vedna other than pani pada region. 3. Patients on medication of hormonal therapy.

Design outcomes

Primary

MeasureTime frame
cure the disease completely.Timepoint: 28 days

Secondary

MeasureTime frame
prevent the relapse of disease.Timepoint: follow up after 7days, 14 days, 21 days, 28 days

Countries

India

Contacts

Public ContactDr Parwez Ahmad Ansari

Government P.G Ayurvedic College and Hospital Varanasi

drpaansari@gmail.com8081373553

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026